potassium bitartrate 900 MG / sodium bicarbonate 600 MG Rectal Suppository [Ceo-Two]
RxNorm concept 636188, branded drug (sbd). Prescribable name: CEO-TWO 0.9 GM / 0.6 GM Rectal Suppository.
- RxCUI
- 636188
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/636188 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Ceo-Two (potassium bitartrate 0.9 GM / sodium bicarbonate 0.6 GM) Rectal Suppository; K+ bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository [Ceo-Two]; Pot bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository [Ceo-Two]
Related concepts
- sodium bicarbonate 600 MG (SCDC, consists of)
- potassium bitartrate 900 MG (SCDC, consists of)
- potassium bitartrate 900 MG / sodium bicarbonate 600 MG [Ceo-Two] (SBDC, consists of)
- Rectal Suppository (DF, has dose form)
- Ceo-Two (BN, has ingredient)
- potassium bitartrate 900 MG / sodium bicarbonate 600 MG Rectal Suppository (SCD, tradename of)
Linked data
NDCs
- 00283080811
- 00283080812
- 00283080836
- 00283102300
- 00283102302
- 00283102336
- 00283102354
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 636188 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/636188 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 636188. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.